The Venture Codex Logo

The Venture Codex

Everest VC

SOHO Building Zhongguancun, Beijing, Haidian District, 100000, China

Overview

Everest Venture Capital Investment Co.,Ltd was founded by Mr.Xiao Jiancong in September 2007. The founder and his team focus on high-tech venture capital investments for the past 12 years. In 2018, Everest Venture capital was awarded with the top 10 most active private equity investment institutions and the top 50 best venture capital institutions in China. They have 140 employees with rich industrial experience, and two offices in both Beijing and Shenzhen to cover the investments in the whole Mainland China area. Everest Venture Capital has achieved a great social value of Science and Technology. They only invest the enterprises with positive value for society. At the same time, they also keep the value proposition that they won’t sell the future for a short-term profit. Regarding the founder of enterprise whom they invested, they not only inject funds but also inject the management style of being excellent. They always share their unique management philosophy with their portfolio companies about the ideas “three-high and one-low”--high satisfaction degree from customers, high rate of return for shareholders, high salary income to employees, and low comprehensive cost. And they believe these will define the greatness of enterprise ultimately.

Total investments
1
Lead investments
0
Investments · 12mo
0
Active investors
9

Sector focus

  • Finance
  • Financial Services
  • Venture Capital
Visit website

Investment portfolio

  • Shukun Technology

    Participated · Series B · Aug 2020

    Shukun is a Chinese startup that uses AI to power medical imaging diagnosis. The company develops AI-driven tools for diagnosing medical images. It secured 700 million yuan (about $108 million) in a new funding round. The round was led by Goldman Sachs and Primavera Capital Group. The funding was announced on Monday. The article does not provide operating metrics, use of proceeds, or details on other investors. Shukun is a Beijing-based artificial intelligence startup focused on medical diagnostics. Its core product, CoronaryDoc, is an assisting software launched in early 2018 that helps doctors diagnose heart disease using visual recognition technologies. By the end of September 2019 CoronaryDoc had been used on a trial basis in more than 100 hospitals in China. In February the company launched an AI system to help diagnose COVID-19, which has been deployed in multiple hospitals including Wuhan Zhongxin Hospital. Shukun plans to use new funding to expand application of its AI technologies for cardiovascular and neurological diseases and cancer detection across hospitals nationwide, with emphasis on grass‑root medical institutions. The company was founded in 2017.

Team

  • Yunxi Li

    Co-founder

  • Jiancong Xiao

    Founder

  • Kai Shen

    Co-founder

  • Xianhong Liang

    Co-founder